Revefenacin

Revefenacin is a synthetic anticholinergic agent that is used as a once daily, nebulized inhalant for maintenance treatment of patients with chronic obstructive pulmonary disease. Revefenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. It is grouped under the following drug class(es): Anticholinergics and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Yupelri, revefenacinum and TD-4208. Its PubChem CID is 11753673.

CAS No 864750-70-9
Molecular Formula C35H43N5O4
Molecular Weight 597.7 g/mol
Synonyms [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate

Frequently Asked Questions